Filter
289
Text search:
ncov
Featured
Recommendations
53
New Publications
1
Language
Document type
Guidelines
149
Studies & Reports
39
Fact sheets
35
Manuals
21
Strategic & Response Plan
15
Training Material
7
Infographics
5
No document type
5
Online Courses
4
Situation Updates
3
Resource Platforms
3
Brochures
2
Videos
1
Countries / Regions
Brazil
22
Russia
22
Syria
15
Middle East and North Africa
15
Latin America and the Carribbean
13
Global
12
Yemen
10
Mozambique
8
West and Central Africa
8
Western and Central Europe
8
South Sudan
7
Angola
7
Africa
7
East and Southern Africa
6
Guinea-Bissau
4
Germany
4
South–East Asia Region
4
Eastern Europe and Central Asia
4
Nigeria
3
India
3
South Africa
3
Bangladesh
3
Colombia
3
Italy
3
Spain
3
Philippines
2
China
2
Indonesia
2
Ecuador
2
Chile
2
Western Pacific Region
2
Paraguay
2
Kazakhstan
2
Vietnam
2
Belarus
2
Burkina Faso
1
Sierra Leone
1
Congo, Democratic Republic of
1
Saudi Arabia
1
Ethiopia
1
Somalia
1
Iraq
1
Chad
1
Kenya
1
Tanzania
1
Cambodia
1
Thailand
1
Malaysia
1
Singapore
1
Malawi
1
Sudan
1
Argentina
1
Ukraine
1
Bolivia
1
Myanmar / Burma
1
Eastern Europe
1
Laos
1
Australia
1
Japan
1
France
1
Mauritius
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
128
Key Resources
10
Women & Child Health
8
Clinical Guidelines
7
Public Health
5
Pharmacy & Technologies
4
Capacity Building
2
Toolboxes
COVID-19
251
Rapid Response
8
HIV
7
Caregiver
7
Mental Health
5
Planetary Health
3
2.0 Rapid Response
3
Polio
2
Refugee
2
Pharmacy
2
Ebola & Marburg
1
Conflict
1
Zika
1
TB
1
AMR
1
Health Financing Toolbox
1
NCDs
1
Orientations provisoires
Interim guidance. 12 May 2021. The Continuity of essential health services: Facility Assessment Tool can be used by countries to rapidly assess the capacity of health facilities to maintain the provision of essential health services during the COVID-19 pandemic. It can help to alert the authorities
...
Countries across the world are facing diverse epidemiological situations with varying response
capacities and access to life saving tools. The World Health Organization (WHO) recommends that national authorities continue to apply a risk-based approach when implementing measures related to COVID-19
...
Orientations provisoires 19 juillet 2021
9 Febr. 2022
The COVID Covovax™ (SIIPL) and Nuvaxovid™ (Novavax) vaccine explainer includes key vaccine specific information on the vaccine specific requirements.
Contact tracing and quarantine in the context of COVID-19: interim guidance, 6 July 2022
recommended
Contact tracing for COVID-19 is the process of identifying, assessing, and managing people who have been exposed to someone who has been infected with the SARS-CoV-2 virus, while quarantine is the separation of contacts from other people after exposure to a probable or confirmed case of SARS-CoV-2 i
...
The World Health Organization (WHO) recognizes the challenges countries face for maintaining their COVID-19 response while addressing competing public health challenges, conflicts, climate change and economic crises.
It remains critical for national programmes to continue to offer testing for COVI
...
This document aims to provide global guidance on poliomyelitis (polio) surveillance in the context of the COVID-19 pandemic. It comes as a technical complement to Polio eradication programme continuity, Immunization in the context of COVID-19 pandemic frequently asked questions, and is aligned with
...
As the Americas undergo profound demographic change and there are more persons aged 65 years or older than children younger than 5 years, it is crucial to recognize that national immunization programs must be redesigned to ensure comprehensive protection for individuals across the lifespan. By adopt
...
First published in 2020, this toolkit is intended for clinicians working in acute care, managing adult and paediatric patients with acute respiratory infection, including severe pneumonia, acute respiratory distress syndrome, sepsis and septic shock. The main objective is to provide key tools for us
...
Right now, we are facing an unpredictable and highly dynamic situation as a global community. However, as we have seen from the solidarity, support and power of communities in the HIV epidemic and already in communities responding to the COVID-19 pandemic, the response must not be fear and stigma. W
...
Orientations provisoires
6 avril 2020
Le présent document résume les recommandations de l’OMS sur l’utilisation rationnelle de l’équipement de protection individuelle (EPI) dans les établissements de santé et lors des soins à domicile, ainsi que lors de la manipulation des cargaison
...
Esta nota de instrução resume as principais considerações em Saúde Mental e Apoio Psicossocial (SMAPS) referen-tes ao novo surto de coronavírus (COVID-19). Este documento foi atualizado pela última vez em 17 de março de 2020.
Para isso, propõe-se utilizar como marco de referência a pirâmide de intervenções para os serviços de SMAPS do Comitê Permanente Interagências (IASC). A pirâmide ilustra diferentes níveis de apoio que variam desde a integração de considerações sociais, de segurança e relativas às nec
...
Documento de informação sintético
Interim guidanceAnnex to: Policy considerations for implementing a risk-based approach to international travel in the context of COVID-19, 2 July 2021
- Module 1: Understanding modelling approaches for sexual, reproductive, maternal, newborn, child and adolescent health, and nutrition
Coronavirus disease 2019 (COVID-19) has a wide range of documented effects. It directly causes death and disability for some people infected. However, disruption to
...
Les pays du monde entier sont confrontés à des situations épidémiologiques diverses, et disposent de capacités de réaction différentes et d’un accès inégal aux outils permettant de sauver des vies. L’Organisation mondiale de la Santé (OMS) recommande aux autorités nationales de contin
...
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition
...
